1 hour ago
Wave Life Sciences (WVE) Plummets 30% Following INLIGHT Obesity Trial Results
Wave Life Sciences (WVE) stock plunged 30% after INLIGHT Phase 1 obesity trial data revealed modest results, sparking questions about competitive position.
The post Wave Life Sciences (WVE) Plummets 30% Following INLIGHT Obesity Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 40 minutes ago
Commercial Metals Company (CMC) Stock Slips 2.19% Despite Q2 Revenue Climbing to...
- 58 minutes ago
Oklo (OKLO) Stock Plunges 50% in Half a Year — Should Investors Buy the Dip?
- 1 hour ago
Coinbase (COIN) Stock Rises as Bitcoin-Backed Home Loans Get Fannie Mae Approval
- 1 hour ago
Kodiak Sciences (KOD) Stock Surges as Zenkuda Eye Treatment Achieves Phase 3 Suc...
- 1 hour ago
MARA Holdings (MARA) Stock Surges 10% Following Strategic $1B Debt Elimination
